Ultrashort gonadotropin-releasing hormone agonist combined with flexible multidose gonadotropin-releasing hormone antagonist for poor responders in in vitro fertilization/embryo transfer programs

Fertility and Sterility

Volumn 90, Issue 1, 2008, Pages 228-230

  Orvieto, Raoul ^a,b   Kruchkovich, Jenny ^a   Rabinson, Jacob ^a   Zohav, Efraim ^a,b   Anteby, Eyal Y ^a,b   Meltcer, Simion ^a  

^a BARZILAI MEDICAL CENTER   (Israel)

^b BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

CETRORELIX; TRIPTORELIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ECHOGRAPHY; EMBRYO TRANSFER; FEMALE; FERTILIZATION IN VITRO; HORMONE ACTION; HUMAN; OOCYTE RETRIEVAL; OVARY HYPERSTIMULATION; PREGNANCY; PRIORITY JOURNAL; TREATMENT RESPONSE;

ADULT; CHORIONIC GONADOTROPIN; DRUG ADMINISTRATION SCHEDULE; EMBRYO TRANSFER; FEMALE; FERTILITY AGENTS, FEMALE; FERTILIZATION IN VITRO; GONADOTROPIN-RELEASING HORMONE; HORMONE ANTAGONISTS; HUMANS; OOCYTE RETRIEVAL; OVULATION INDUCTION; PREGNANCY; PREGNANCY RATE; SPERM INJECTIONS, INTRACYTOPLASMIC; TREATMENT FAILURE; TREATMENT OUTCOME; TRIPTORELIN;

EID: 45849093342     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2007.06.022     Document Type: Article

References (18)

1. Penzias A.S. Improving results with assisted reproductive technologies: individualized patient-tailored strategies for ovulation induction. Reprod Biomed Online 9 (2004) 43-46
2. Ben-Rafael Z., Orvieto R., and Feldberg D. The poor-responder patient in an in-vitro fertilization-embryo transfer (IVF-ET) program. Gynecol Endocrinol 8 (1994) 277-286
3. Mahutte N.G., and Arici A. Role of gonadotropin-releasing hormone antagonists in poor responders. Fertil Steril 87 (2007) 241-249
4. Mitwally M.F., and Casper R.F. Aromatase inhibition improves ovarian response to follicle-stimulating hormone in poor responders. Fertil Steril 77 (2002) 776-780
5. Surrey E.S., and Schoolcraft W.B. Evaluating strategies for improving ovarian response of the poor responder undergoing assisted reproductive techniques. Fertil Steril 73 (2000) 667-6
6. Berger B.M., Ezcurra D., and Alper M.M. The agonist-antagonist protocol: a novel protocol for treating the poor responder. [abstract]. Fertil Steril 82 Suppl 2 (2004) S126
7. Lisi F. To add or not to add LH: comments on recent commentaries. Reprod Biomed Online 12 (2006) 415-417
8. Ben-Rafael Z., Lipitz S., Bider D., and Mashiach S. Ovarian hyporesponsiveness in combined gonadotropin-releasing hormone-agonist and menotropin therapy is associated with low serum follicle-stimulating hormone level. Fertil Steril 55 (1991) 272-275
9. Sheehan K.L., Casper R.F., and Yen S.S.C. Induction of luteolysis by luteinizing hormone-releasing factor (LRF) agonist: sensitivity, reproducibility, and reversibility. Fertil Steril 37 (1982) 209-212
10. Scott R.T., and Navot D. Enhancement of ovarian responsiveness with microdoses of gonadotropin-releasing hormone agonist during ovulation induction for in vitro fertilization. Fertil Steril 61 (1994) 880-885
11. Surrey E., Bower J., Hill D., Ramsey J., and Surrey M. Clinical and endocrine effects of a microdose GnRH agonist flare regimen administered to poor responders who are undergoing in vitro fertilization. Fertil Steril 69 (1998) 419-424
12. Fasouliotis S.J., Laufer N., Sabbagh-Ehrlich S., Lewin A., Hurwitz A., and Simon A. Gonadotropin-releasing hormone (GnRH)-antagonist versus GnRH-agonist in ovarian stimulation of poor responders undergoing IVF. J Assist Reprod Genet 20 (2003) 455-460
13. Malmusi S., La Marca A., Giulini S., Xella S., Tagliasacchi D., Marsella T., et al. Comparison of a gonadotropin-releasing hormone (GnRH) antagonist and GnRH agonist flare-up regimen in poor responders undergoing ovarian stimulation. Fertil Steril 84 (2005) 402-406
14. Posada M.N., Vlahos N.P., Jurema M.W., Bracero N.J., Wallach E.E., and Garcia J.E. Clinical outcome of using ganirelix acetate versus a 4-day follicular phase leuprolide acetate protocol in unselected women undergoing in vitro fertilization. Fertil Steril 80 (2003) 103-110
15. Demirol A., Girgin B., and Gurgan T. Comparison of microdose flare-up and antagonist multiple dose protocols in poor responder patients. [abstract]. Fertil Steril 84 (2005) S325
16. Hollett-Caines J., Feyles V., Rebel M., Power S., Tekpetey F., and Abu-Rafea B. Comparing a microdose flare to a GnRH antagonist protocol for poor responder patients undergoing in-vitro fertilization. [abstract]. Fertil Steril 84 (2005) S432
17. Detti L., Williams D.B., Robins J.C., Maxwell R.A., and Thomas M.A. Comparison of three downregulation approaches for poor responders undergoing in vitro fertilization. Fertil Steril 84 (2005) 1401-1405
18. Morgia F., Sbracia M., Schimberni M., Giallonardo A., Piscitelli C., Giannini P., et al. A controlled trial of natural cycle versus microdose gonadotropin-releasing hormone analog flare cycles in poor responders undergoing in vitro fertilization. Fertil Steril 81 (2004) 1542-1547